Protagonist Net Working Capital from 2010 to 2024

PTGX Stock  USD 29.98  0.43  1.41%   
Protagonist Therapeutics Net Working Capital yearly trend continues to be fairly stable with very little volatility. Net Working Capital will likely drop to about 227.5 M in 2024. During the period from 2010 to 2024, Protagonist Therapeutics Net Working Capital regression line of annual values had r-squared of  0.59 and arithmetic mean of  162,280,236. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
334.3 M
Current Value
227.5 M
Quarterly Volatility
82.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Protagonist Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protagonist main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 M, Interest Expense of 4.1 M or Selling General Administrative of 18 M, as well as many exotic indicators such as Price To Sales Ratio of 20.61, Dividend Yield of 0.0 or PTB Ratio of 4.06. Protagonist financial statements analysis is a perfect complement when working with Protagonist Therapeutics Valuation or Volatility modules.
  
This module can also supplement Protagonist Therapeutics' financial leverage analysis and stock options assessment as well as various Protagonist Therapeutics Technical models . Check out the analysis of Protagonist Therapeutics Correlation against competitors.
For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.

Latest Protagonist Therapeutics' Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Protagonist Therapeutics over the last few years. It is Protagonist Therapeutics' Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Protagonist Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Protagonist Net Working Capital Regression Statistics

Arithmetic Mean162,280,236
Geometric Mean146,492,488
Coefficient Of Variation50.96
Mean Deviation71,255,515
Median108,392,000
Standard Deviation82,696,865
Sample Variance6838.8T
Range225.9M
R-Value0.77
Mean Square Error3041.1T
R-Squared0.59
Significance0.0009
Slope14,168,510
Total Sum of Squares95742.8T

Protagonist Net Working Capital History

2024227.5 M
2023334.3 M
2022211.9 M
2021296.7 M
2020275.4 M
2019109.9 M
2018111.3 M

About Protagonist Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Protagonist Therapeutics income statement, its balance sheet, and the statement of cash flows. Protagonist Therapeutics investors use historical funamental indicators, such as Protagonist Therapeutics's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Protagonist Therapeutics investors may use each financial statement separately, they are all related. The changes in Protagonist Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Protagonist Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Protagonist Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Protagonist Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital334.3 M227.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Protagonist Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Protagonist Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Protagonist Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Protagonist Therapeutics Stock:
Check out the analysis of Protagonist Therapeutics Correlation against competitors.
For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.
Note that the Protagonist Therapeutics information on this page should be used as a complementary analysis to other Protagonist Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Protagonist Stock analysis

When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Protagonist Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagonist Therapeutics. If investors know Protagonist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagonist Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
2.54
Revenue Per Share
5.308
Quarterly Revenue Growth
(1.00)
Return On Assets
0.2138
Return On Equity
0.4175
The market value of Protagonist Therapeutics is measured differently than its book value, which is the value of Protagonist that is recorded on the company's balance sheet. Investors also form their own opinion of Protagonist Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagonist Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagonist Therapeutics' market value can be influenced by many factors that don't directly affect Protagonist Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagonist Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagonist Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagonist Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.